CN101428040A - Tigason powder - Google Patents
Tigason powder Download PDFInfo
- Publication number
- CN101428040A CN101428040A CNA200810237134XA CN200810237134A CN101428040A CN 101428040 A CN101428040 A CN 101428040A CN A200810237134X A CNA200810237134X A CN A200810237134XA CN 200810237134 A CN200810237134 A CN 200810237134A CN 101428040 A CN101428040 A CN 101428040A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- psoriatic
- medicine
- tigason
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese herbal medicine and discloses a psoriatic powder. The psoriatic powder comprises the following drugs according to the parts by weight: 70-150 parts of ground beetles, 80-150 parts of scorpios, 90-150 parts of centipedes, and 50-150 parts of leeches. The psoriatic powder adopts the compatibility concept that the formula takes the scorpios as monarch, the centipedes as minister, the ground beetles as adjuvant and the leeches as dispatcher. The psoriatic powder can be used for curing the psoriasis by adopting the principles of fighting poison with poison, activating blood and dissolving stasis and dispelling wind and arresting itching, and the effect is very remarkable through practice.
Description
Technical field
The present invention relates to Chinese herbal medicine, more specifically relate to a kind of Tigason powder.
Background technology
It is a kind of common chronic inflammatory disease dermatoses that is easy to recur that psoriasis is commonly called as " psoriasis ", and the characteristic infringement is for being covered with the silvery white squama of multilamellar on red pimple or the speckle.The maximum male's morbidities of between twenty and fifty morbidity are more than the women, and the north is more than south, and easily send out or increase the weight of to alleviate summer and autumn more winter in spring.The cause of disease and pathogeny are fully clear and definite, and the morbidity of discovering primary disease and inherited genetic factors, infection streptococcus, immunologic dysfunction dysbolismus and hormonal change etc. are relevant.There are four types clinically: homeliness type, pustular type erythrodermic and arthrosis type.Psoriasis vulgaris is the most common, and the light primary disease of the state of an illness is chronic process, cures back recurrence easily.The traditional Chinese medical science is accumulating rich experience aspect the treatment psoriasis, as, Chinese patent Granted publication day is on March 30th, 2005, Granted publication CN 1194714C, the patent No. to be that ZL 01128375.0, name are called " treating psoriatic Chinese medicine " disclosed technical scheme, this drug effect really remains practice test, for this reason, remain the psoriatic Chinese medicine composition of the good treatment of development effectiveness.
Summary of the invention
Purpose of the present invention: provide a kind of treatment psoriatic Tigason powder.
Technical scheme of the present invention is: a kind of Tigason powder, its key are that this medicine is made up of the medicine of following weight portion proportioning:
Eupolyphaga Seu Steleophaga 70-150 part; Scorpio 80-150 part; Scolopendra 90-150 part; Hirudo 50-150 part.
Described Tigason powder, its this medicine optimum formula is made up of the medicine of following weight portion proportioning: 100 parts of Eupolyphaga Seu Steleophagas;
100 parts of Scorpio; 100 parts of Scolopendras; 100 parts of Hirudos.
Compatibility thought of the present invention: this side is monarch with the Scorpio, is minister with the Scolopendra, is assistant with the Eupolyphaga Seu Steleophaga, with Hirudo for making.
Raw material effect of the present invention:
Eupolyphaga Seu Steleophaga: this product is the female worm dry body of Corydiidae insecticide eupolyphoge sinensis or Ji eupolyphoge sinensis; Salty, cold; Slightly poisonous, return Liver Channel; Removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; Be used for the muscles and bones folding and hinder blood stasis amenorrhea, lump in the abdomen mass in the abdomen.
Scorpio: its main medicinal ingredient is a charybdotoxin; Has " spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., antiinflammatory counteracting toxic substances, removing obstruction in the collateral to relieve pain " function; Cure mainly diseases such as " infantile convulsion, tic spasm, dermatosis, cardiovascular and cerebrovascular disease, inflammation, hepatitis B, tumors ";
Scolopendra: be Myriapoda, Scolopendridae; Salty, hot, temperature.Poisonous.Return liver, spleen, lung meridian; Relieve internal heat anticancer, relieving spasm by calming endogenous wind, move back inflammation and control skin ulcer.
Hirudo: be Annelida, Hirudo guiding principle, pharynx trematodiasis order, Hirudinidae; Salty hardship, flat, poisonous; Stimulate the menstrual flow the removing blood stasis with potent drugs detumescence; Diseases such as menstruation apolipsis, lump in the abdomen stomachache, blood-retention, traumatic blood stasis are had a pain, carbuncle erysipelas.
Manufacture method of the present invention: pulverize and be the end.
Usage of the present invention and consumption: obey 3 grams, be a course of treatment at twice, 7 day every day at every turn.See produce effects 2-4 the course of treatment.
Beneficial effect of the present invention: Tigason powder of the present invention adopts treating the poisonous disease with poisonous drugs, blood circulation promoting and blood stasis dispelling, and the principle treatment psoriasis of dispelling wind for relieving itching is through facts have proved its effect highly significant.
The specific embodiment
Below by embodiment, the invention will be further described.
Embodiment 1
A kind of Tigason powder, this medicine is made up of the medicine of following weight portion proportioning:
70 parts of Eupolyphaga Seu Steleophagas; 80 parts of Scorpio; 90 parts of Scolopendras; 50 parts of Hirudos.
Embodiment 2
A kind of Tigason powder, this medicine is made up of the medicine of following weight portion proportioning:
150 parts of Eupolyphaga Seu Steleophagas; 150 parts of Scorpio; 150 parts of Scolopendras; 150 parts of Hirudos.
Embodiment 3
A kind of Tigason powder, this medicine is made up of the medicine of following weight portion proportioning:
100 parts of Scorpio; 100 parts of Scolopendras; 100 parts of Hirudos.
Claims (2)
1, a kind of Tigason powder is characterized in that, this medicine is made up of the medicine of following weight portion proportioning:
Eupolyphaga Seu Steleophaga 70-150 part; Scorpio 80-150 part; Scolopendra 90-150 part; Hirudo 50-150 part.
2, according to claims 1 described Tigason powder, it is characterized in that this medicine is made up of the medicine of following weight portion proportioning:
100 parts of Eupolyphaga Seu Steleophagas; 100 parts of Scorpio; 100 parts of Scolopendras; 100 parts of Hirudos.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200810237134XA CN101428040A (en) | 2008-12-19 | 2008-12-19 | Tigason powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200810237134XA CN101428040A (en) | 2008-12-19 | 2008-12-19 | Tigason powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101428040A true CN101428040A (en) | 2009-05-13 |
Family
ID=40643808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200810237134XA Pending CN101428040A (en) | 2008-12-19 | 2008-12-19 | Tigason powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101428040A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755502A (en) * | 2012-08-06 | 2012-10-31 | 廖丽萍 | External use washing liquor for relieving psoriasis |
-
2008
- 2008-12-19 CN CNA200810237134XA patent/CN101428040A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755502A (en) * | 2012-08-06 | 2012-10-31 | 廖丽萍 | External use washing liquor for relieving psoriasis |
| CN102755502B (en) * | 2012-08-06 | 2013-12-25 | 廖丽萍 | External use washing liquor for relieving psoriasis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742994A (en) | Chinese foot-soaking powder | |
| CN103432225A (en) | Chinese medicinal preparation used for treating rheumatism | |
| CN106039023A (en) | Drug for treating shingles and postherpetic neuralgia thereof | |
| CN105687409A (en) | Stone needle mud moxibustion and method for preparing same | |
| CN102178918B (en) | Externally applied Chinese medicine for treating sprain | |
| CN103100016B (en) | Chinese medicament for treating pruritus cutanea | |
| CN104225283B (en) | A kind of oral medicinal herb medicine and plaster for treating cervical vertebra, scapulohumeral periarthritis, protrusion of lumber intervertebral disc, rheumatic arthritis and rheumatoid arthritis | |
| CN101428040A (en) | Tigason powder | |
| CN102302637A (en) | Plaster for treating chilblain and preparation method thereof | |
| CN1424070A (en) | Plaster | |
| CN104083568A (en) | Miao medicine plaster for ostealgia and preparation method thereof | |
| CN104208635A (en) | Externally used traditional Chinese medicine composition for relieving pain and preparation method thereof | |
| CN101085046A (en) | External-applied medicine for treating pruritus skin diseases and its preparation method | |
| CN101632756B (en) | Traditional Chinese medicine for treating malignant tumours and preparation method thereof | |
| CN102872312A (en) | Dermatitis treating medicine | |
| CN103585403B (en) | A kind of Chinese medicine for the treatment of dysmenorrhea | |
| CN103007050B (en) | External Chinese medicament for drawing out poison | |
| CN100998620A (en) | External use medicine for treating herpes zoster | |
| CN101569679B (en) | Chinese medicinal composition for treating tenosynovitis and preparation method thereof | |
| CN101985030A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN104288395A (en) | Black plaster for treating rheumatoid arthritis and preparation method of black plaster | |
| CN103251779B (en) | Traditional Chinese medicine ointment specially used for treating swine frostbite | |
| CN102671027B (en) | Traditional Chinese medicine for curing calculi in urinary system | |
| CN102626479B (en) | External-use Chinese herbal medicine composition for chronic rheumatism treatment | |
| CN101822811A (en) | Medicine treating pancreatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090513 |